Pharmaceutical Business Intelligence

  • Formulary management
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010209

« Back to Dashboard
NDA 010209 describes METI-DERM, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the METI-DERM profile page.

The generic ingredient in METI-DERM is prednisolone. There are eighty-five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the prednisolone profile page.

Summary for NDA: 010209

Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No
SELECT DISTINCT m.Applicant, m.Tradename, m.Ingredient, m.Dosage, CONCAT(m.NDA,'-',m.Number) AS NDA, m.Approvaldate, p.patentnumber as Patentnumber, a.expiredate as arch_expiredate FROM master m JOIN master_archives a ON (m.NDA = a.NDA and m.Number = a.Number) JOIN patentdetails p ON (a.Patentnumber = p.Patentnumber) WHERE m.NDA = "010209" AND a.expiredate < CURDATE() ORDER BY RAND(104)
Illegal mix of collations (utf8mb4_general_ci,IMPLICIT) and (utf8mb4_unicode_ci,IMPLICIT) for operation '='